ReviewSmall methods2026
Application-Driven Modular Design of Gold Nanoclusters for In Vivo Fluorescence Imaging.
Review in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Atomically precise gold nanoclusters (AuNCs) combine ultrasmall size (<3 nm), large Stokes shifts, high photostability, favorable biocompatibility, efficient renal clearance, and tunable second near-infrared emission, which enables deep‑tissue imaging with minimal background interference. These attributes offer distinct advantages over conventional fluorescent probes in terms of biosafety, tissue penetration, and signal‑to‑background ratio, making AuNCs highly promising candidates for in vivo fluorescence imaging. Existing reviews have systematically cataloged synthetic methods and imaging applications, but rarely establish direct correlations between structural design and specific imaging demands. This review adopts an application‑driven reverse design logic. Starting from the physiological constraints and imaging requirements of representative diseases, we translate these demands into modular structural configurations of the metallic core, surface chemistry, and assembly structure. By analyzing representative in vivo scenarios, we extract universal design principles and discuss the coupling effects and trade‑offs among the three modules. This framework offers theoretical insights and actionable strategies for developing high‑performance AuNC probes tailored to complex biological environments, with the aim of bridging the gap between material‑oriented research and clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.